mTOR is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Por Mabuchi, Seiji, Kawase, Chiaki, Altomare, Deborah A., Morishige, Kenichirou, Sawada, Kenjiro, Hayashi, Masami, Tsujimoto, Masahiko, Yamoto, Mareo, Klein-Szanto, Andres J., Schilder, Russell J., Ohmichi, Masahide, Testa, Joseph R., Kimura, Tadashi
Publicado em 2009